Drug Lobby Widens Industry Pricing Challenges To Texas
A group that represents major pharmaceutical companies has lobbed yet another challenge to landmark legislation allowing Medicare to negotiate drug prices, saying in the lawsuit filed in Texas federal court Wednesday...To view the full article, register now.
Already a subscriber? Click here to view full article